Products for Research Use Only
RegisterLogin

HDAC-IN-39

CAT: 0804-HY-146392Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-146392Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HDAC-IN-39 (compound 16c) is a potent HDAC inhibitor, with IC50 values of 1.07 μM (HDAC1), 1.47 μM (HDAC2), and 2.27 μM (HDAC3), respectively. HDAC-IN-39 also significantly inhibits microtubule polymerization. HDAC-IN-39 induces cell cycle arrest at the G2/M phase. HDAC-IN-39 displays promising anticancer activity against resistant cancer cells[1].
CAS Number
2414046-33-4
UNSPSC
12352005
Target
Apoptosis; HDAC; Microtubule/Tubulin
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-39.html
Solubility
10 mM in DMSO
Smiles
COC1=CC=C(C=C1)S(=O)(NC2=CC=CC=C2NCC3=CC=C(C=C3)C(NC4=CC=CC=C4N)=O)=O
Molecular Formula
C27H26N4O4S
Molecular Weight
502.58
References & Citations
[1]Wu WC, et al. Design, synthesis, and evaluation of N-phenyl-4- (2-phenylsulfonamido) -benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response. Eur J Med Chem. 2020 Apr 15;192:112158.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC2; HDAC3; HDAC8

Related Products

CatalogName
HY-160845HDAC6-IN-39
HY-161688HDAC-IN-73
HY-161984HDAC-IN-76
HY-149370HDAC-IN-60
HY-142965HDAC-IN-28
HY-147892HDAC-IN-42
HY-162487HDAC-IN-72
HY-147966HDAC-IN-43
HY-18362HDAC-IN-5
HY-150597HDAC-IN-46

Alternative Products

CatalogName
GTR19185238-01HDAC-IN-39
T211349-01HDAC-IN-91
T210046-01HDAC-IN-75
T205411-01HDAC-IN-85
T203306-01HDAC-IN-82
T201210-01HDAC-IN-81
T200090-01HDAC-IN-76
T62514-01HDAC-IN-46
T62072-01HDAC-IN-47
T72012-01HDAC-IN-6

Popular Products